» Authors » Christopher Rajkumar

Christopher Rajkumar

Explore the profile of Christopher Rajkumar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Warisawa T, Cook C, Ahmad Y, Howard J, Seligman H, Rajkumar C, et al.
Cardiovasc Interv Ther . 2024 Apr; 39(3):241-251. PMID: 38642290
Despite guideline-based recommendation of the interchangeable use of instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) to guide revascularization decision-making, iFR/FFR could demonstrate different physiological or clinical outcomes in...
2.
Warisawa T, Cook C, Ahmad Y, Howard J, Seligman H, Rajkumar C, et al.
Circ Cardiovasc Interv . 2023 Jun; 16(6):e012700. PMID: 37339234
Background: The majority of randomized controlled trials of revascularization decision-making excludes left main coronary artery disease (LMD). Therefore, contemporary clinical outcomes of patients with stable coronary artery disease and LMD...
3.
Rajkumar C, Simader F, Al-Lamee R
Heart . 2023 Jun; 109(19):1422-1423. PMID: 37290899
No abstract available.
4.
Warisawa T, Cook C, Kawase Y, Howard J, Ahmad Y, Seligman H, et al.
Cardiovasc Interv Ther . 2023 Apr; 38(3):287-298. PMID: 37017899
There have been no studies comparing clinical outcomes of physiology-guided revascularization in patients with unprotected left main coronary disease (ULMD) between percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting...
5.
Nowbar A, Howard J, Shun-Shin M, Rajkumar C, Foley M, Basu A, et al.
Eur Heart J Digit Health . 2023 Jan; 3(2):276-283. PMID: 36713021
Aims: The traditional approach to documenting angina outcomes in clinical trials is to ask the patient to recall their symptoms at the end of a month. With the ubiquitous availability...
6.
Maznyczka A, Rajkumar C, Hobson A, Haworth P
BMJ Case Rep . 2022 Jun; 15(6). PMID: 35688575
We present a case of angina, where extreme coronary tortuosity affected invasive physiology interpretation. Extreme coronary tortuosity may lower fractional flow reserve and instantaneous wave-free ratio. Therefore, invasive physiology can...
7.
Nowbar A, Rajkumar C, Foley M, Ahmed-Jushuf F, Howard J, Seligman H, et al.
EuroIntervention . 2022 Feb; 17(18):1490-1497. PMID: 35156616
Percutaneous coronary intervention (PCI) is frequently performed for stable angina. However, the first blinded trial, ORBITA, did not show a placebo-controlled increment in exercise time in patients with single-vessel disease,...
8.
Al-Lamee R, Foley M, Rajkumar C, Nowbar A
EuroIntervention . 2021 Dec; 17(12):e963-e965. PMID: 34916182
No abstract available.
9.
Hartley A, Shun-Shin M, Caga-Anan M, Rajkumar C, Nowbar A, Foley M, et al.
Front Cardiovasc Med . 2021 Oct; 8:757030. PMID: 34708098
Malondialdehyde-modified low-density lipoprotein (MDA-LDL) forms a significant component of oxidised LDL. The effects of exercise on levels of MDA-LDL and anti-MDA-LDL antibodies are not well-understood. Furthermore, it is not known...
10.
Seligman H, Nijjer S, van de Hoef T, de Waard G, Mejia-Renteria H, Echavarria-Pinto M, et al.
EuroIntervention . 2021 Aug; 17(15):1260-1270. PMID: 34338643
Background: Coronary blood flow in humans is known to be predominantly diastolic. Small studies in animals and humans suggest that this is less pronounced or even reversed in the right...